17-β estradiol 0.5 mg days 1–21/dydrogesterone 10 mg days 11–21 (n = 12) Control (n = 33) No difference between groups Subjects that resumed menses: ↑ LS BMD 4% (p = 0.008); ↑ hip BMD 3% ...